Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,214.1
19.4 (0.61%)

 

  • STI Straits Times Index
    3,214.1
    19.4 (0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    3.8 (0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,687.8
    693.6 (2.57%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,967.7
    52.0 (1.78%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,023.1
    598.3 (2.55%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,197.3
    57.9 (0.94%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,170.2
    32.9 (1.54%)
    Index delayed 20 minutes
  • XAO XAO
    6,844.6
    33.8 (0.50%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 969.2M
  • Value: 1,355.0M
  • Rise: 174
  • Fall: 117
  • Unch: 535

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186+0.007
Golden Agri-Res0.220-
YZJ Shipbldg SGD1.130+0.040
Artivision Tech0.003-0.001
Ascendas Reit2.910-0.080
CapitaMall Trust2.420-0.040
Genting Sing0.930-0.005
ThaiBev0.920+0.010
Mapletree Com Tr2.260-0.020
SingTel3.390-

World Indices

World Indices
Name Last Change
Nasdaq 8,734.9 +17.6
HSI 27,687.8 +693.6
HSCEI 10,838.1 +223.3
Jakarta 6,197.3 +57.9
Nikkei 225 24,023.1 +598.3
SSE Comp 2,967.7 +52.0
Shanghai A 3,109.7 +54.5
Shanghai B 245.9 +3.2
PSE Comp 0.0
KOSPI 2,170.2 +32.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

ILLUMINA INC ILLUMINA
Updated on 13 Dec 2019 (End of trading day)
Last (USD): 324.720 Change: +2.730 High: 326.030 Remarks: -
Change (%): +0.85 Low: 319.570
Open 322.620 Yesterday's Close 321.99
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 621,004 Cumulative Value
 
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 5.61905 Trailing EPS (USD) e 6.61905 NAV (USD) b 30.1973
PE a 57.789 Trailing PE f 49.058 Price / NAV b 10.7533
Dividend (USD) d - Cash In Hand (USD) g 12.3469 Issued & Paid-up Shares c 147,000,000
Dividend Yield (%) d - Price / Cash In Hand g 26.300 Treasury Shares h 45,000,000
Beta - 75 Daysi 0.439 R-Squared - 75 Days(%)i 1.59 Market Cap (M) 47,733.840
Beta - 500 Daysi 0.002 R-Squared - 500 Days (%)i - Enterprise Value (M) 46,438.840
Piotroski F Score 6 Exchange Code ILMN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 39.12 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 12 Feb 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ILLUMINA INC NASDAQ 47,733.840 57.789 49.058 10.7533 -
Industry Biotechnology NASDAQ 2,351.998 405.031 168.111 5.8861 0.743
Local Peer AMGEN INC NASDAQ 140,667.120 16.758 17.437 12.8734 2.363
Local Peer GILEAD SCIENCES INC NASDAQ 83,208.916 15.254 30.898 4.0385 3.513
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,310.707 26.861 26.267 10.7189 -
Local Peer BIOGEN INC NASDAQ 53,560.599 12.089 9.927 3.8269 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 41,329.399 16.908 19.275 3.9345 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,434.952 314.883 16.619 2.3569 -
Local Peer INCYTE CORPORATION NASDAQ 19,710.979 180.021 48.673 8.1365 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,515.724 - - 10.9663 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,400.536 - - 4.6840 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 13,528.983 - 43.591 4.8948 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 13,126.833 - - 8.1681 -
Local Peer EXACT SCIENCES CORP NASDAQ 12,838.630 - - 17.1576 -
Other Local Peers BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), REPLIGEN CORP (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), UNIQURE N.V. (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), NATERA INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CHEMOCENTRYX INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), NEXTCURE INC (NASDAQ), ALECTOR INC (NASDAQ), VERACYTE INC (NASDAQ), VIELA BIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), OMEROS CORP (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), DERMIRA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), RETROPHIN INC (NASDAQ), ARDELYX INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOGEN INC (NASDAQ), AGENUS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), MACROGENICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MERUS B V (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AVID BIOSERVICES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BELLUS HEALTH INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), COMPUGEN (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PERSONALIS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), SERES THERAPEUTICS (NASDAQ), IVERIC BIO INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), NANTKWEST INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), CHIASMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), ATHERSYS INC (NASDAQ), ARAVIVE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), CABALETTA BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), CHIMERIX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), VERASTEM INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), INFLARX N V (NASDAQ), ADURO BIOTECH INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), EQUILLIUM INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), AXCELLA HEALTH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), OTONOMY INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), VERMILLION INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), TREVENA INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), SAVARA INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), RESTORBIO INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ZAFGEN INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SOLIGENIX INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), SENESTECH INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), TOCAGEN INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), OCUGEN INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), BIOCEPT INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TROVAGENE INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), SPHERIX INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Global Peer CSL ASX 126,230.603 47.050 47.050 16.8686 0.954
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,905.566 81.979 24.188 5.4561 0.732
Global Peer SINO BIOPHARM HKEx 129,562.909 12.092 12.549 3.8585 0.710
Global Peer WUXI BIO HKEx 121,568.327 162.763 127.243 12.5139 -
Global Peer BEIGENE HKEx 85,666.018 - - 8.5473 -
Global Peer GENSCRIPT BIO HKEx 34,877.863 209.745 - 9.8354 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 27,025.281 17.865 21.745 2.6637 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,682.899 42.790 623.930 2.5922 -
Other Global Peers HAOHAI BIOTEC (HKEx), ALPHAMAB ONCOLOGY (HKEx), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), POLYNOVO LIMITED (ASX), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), PFENEX INC (NYSE American), TELIX PHARMACEUTIC (ASX), DPHARMA (Bursa), NEXT SCIENCE LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BBI LIFE SCI (HKEx), NANOVIRICIDES INC (NYSE American), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), PALATIN TECHNOLOGIES INC (NYSE American), RESAPP HEALTH LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), IMUGENE LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), CEL-SCI CORP (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), IMMUTEP LTD (ASX), ORTHOCELL LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), ISORAY INC (NYSE American), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), KAZIA THERAPEUTICS LIMITED (ASX), NOVITA HEALTHCARE LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), REGENT PACIFIC (HKEx), BIOTRON (ASX), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), RHINOMED LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), EXTRAWELL PHAR (HKEx), IBIO INC (NYSE American), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), IMMURON LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), CELLMID LIMITED (ASX), REGENEUS LTD (ASX), PATRYS LIMITED (ASX), ANTEOTECH LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), HOLISTA COLLTECH LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CCP TECHNOLOGIES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), BENITEC BIOPHARMA LTD (ASX), MEGASUN (Bursa), HAO WEN HLDGS (HKEx), MGRC (Bursa), SIENNA CANCER DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), BPH ENERGY LIMITED (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.750
-0.54 %
10 Days -+3.960
+1.23 %
20 Days -+18.735
+6.12 %
Medium Term Return 3 Months -+23.810
+7.91 %
6 Months --19.280
-5.60 %
1 Year --1.740
-0.53 %
Long Term Return 2 Years -+108.170
+49.95 %
3 Years -+193.710
+147.86 %
5 Years -+134.750
+70.93 %
Annualised Return Annualised --
+11.32 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 263.300 - 380.760 Change From 1 Year Low +61.420 % Change From 1 Year Low (%) +23.33
Change From 1 Year High -56.040 % Change From 1 Year High (%) -14.72
2 Years Range 207.510 - 380.760 Change From 2 Years Low +117.210 % Change From 2 Years Low (%) +56.48
Change From 2 Years High -56.040 % Change From 2 Years High (%) -14.72
5 Years Range 119.370 - 380.760 Change From 5 Years Low +205.350 % Change From 5 Years Low (%) +172.03
Change From 5 Years High -56.040 % Change From 5 Years High (%) -14.72
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Dec 2019 322.620 326.030 319.570 324.720 621,004 -
12 Dec 2019 320.890 324.930 319.000 321.990 791,453 -
11 Dec 2019 326.000 326.000 317.435 320.570 799,258 -
10 Dec 2019 326.010 329.300 324.110 326.940 789,580 -
09 Dec 2019 326.190 328.050 323.600 326.590 792,062 -
06 Dec 2019 321.000 328.390 319.644 326.470 934,573 -
05 Dec 2019 320.000 321.340 318.990 319.810 467,249 -
04 Dec 2019 321.690 322.415 319.360 319.680 704,592 -
03 Dec 2019 317.520 323.370 315.515 322.970 674,786 -
02 Dec 2019 320.330 321.820 316.770 319.670 832,494 -
29 Nov 2019 320.000 322.784 318.620 320.760 444,339 -
27 Nov 2019 319.820 321.100 318.840 320.940 719,845 -
26 Nov 2019 317.000 321.230 315.275 319.410 1,091,009 -
25 Nov 2019 315.520 318.000 314.210 317.230 713,281 -
22 Nov 2019 313.860 316.000 312.060 315.620 604,408 -
21 Nov 2019 313.940 314.669 309.359 312.850 572,727 -
20 Nov 2019 308.610 315.790 308.387 314.910 1,072,055 -
19 Nov 2019 307.310 313.840 307.000 311.010 860,953 -
18 Nov 2019 305.900 306.850 301.930 306.670 996,500 -
15 Nov 2019 301.050 306.490 299.235 305.985 744,798 -
14 Nov 2019 299.560 300.240 294.897 298.440 562,004 -
13 Nov 2019 295.290 298.650 294.235 298.220 382,784 -
Summary
Current 2 Weeks
(02 Dec 2019 to 13 Dec 2019)		 320.330 329.300 315.515 324.720 7,407,051 -
Previous 2 Weeks
(15 Nov 2019 to 29 Nov 2019)		 301.050 329.300 299.235 320.760 7,819,915 -
4 Weeks from
(18 Oct 2019 to 14 Nov 2019)		 311.260 329.300 307.175 298.440 21,311,190 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.